Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)

SHA:600538 Revenue

In the year 2025, Beihai Gofar Chuanshan Biological had annual revenue of 328.24M CNY, down -3.59%. Beihai Gofar Chuanshan Biological had revenue of 89.17M in the quarter ending December 31, 2025, with 15.82% growth.

• Revenue: 328.24M
• Revenue Growth: -3.59%
• P/S Ratio: 10.73
• Revenue / Employee: 724.59K
• Employees: 453
• Market Cap: 3.52B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	328.24M	-12.23M	-3.59%
Dec 31, 2024	340.47M	-28.69M	-7.77%
Dec 31, 2023	369.15M	-90.53M	-19.69%
Dec 31, 2022	459.68M	34.97M	8.23%
Dec 31, 2021	424.72M	157.02M	58.65%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error